2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
15
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Breast Neoplasms, Male
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Thyroid Diseases
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Prostatic Diseases
1
Parotid Gland Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Obesity
1
Neoplasms by Site
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
Head and Neck Neoplasms
1
Genital Neoplasms, Male
1
Interventions
Ibandronic Acid
8
Gemcitabine
8
Doxorubicin
6
Cyclophosphamide
6
Zoledronic Acid
5
Radiation
4
Nivolumab
4
Irinotecan
4
pembrolizumab
3
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Docetaxel
3
Denosumab
3
Cisplatin
3
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
3
regorafenib
2
pegfilgrastim
2
Tranexamic Acid
2
Trabectedin
2
Surveys and Questionnaires
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiosurgery
2
Quality of Life
2
Proton Therapy
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Biopsy, Needle
×
Clear all
NCT07113301
2025-08-08
INSPECTOR
Istituto Ortopedico Rizzoli
Active not recruiting
42 enrolled